Literature DB >> 3025739

A superfamily of potentially oncogenic hormone receptors.

S Green, P Chambon.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3025739     DOI： 10.1038/324615a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  63 in total

1.  Mutations in the hormone regulatory element of mouse mammary tumor virus differentially affect the response to progestins, androgens, and glucocorticoids.

Authors:  P L Gowland; E Buetti
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

2.  Accumulation of different c-erbA transcripts during rat brain development and in cortical neurons cultured in a synthetic medium.

Authors:  D Castiglia; A Cestelli; C Di Liegro; L Bonfanti; I Di Liegro
Journal:  Cell Mol Neurobiol       Date:  1992-06       Impact factor: 5.046

Review 3.  Nuclear thyroid hormone receptors.

Authors:  M A Lazar; W W Chin
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 4.  TGF-beta: problems and prospects.

Authors:  M B Sporn; A B Roberts
Journal:  Cell Regul       Date:  1990-11

5.  Cooperative activation of a eukaryotic transcription factor: interaction between Cu(I) and yeast ACE1 protein.

Authors:  P Fürst; D Hamer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.

Authors:  V Craig Jordan; Ramona Curpan; Philipp Y Maximov
Journal:  J Natl Cancer Inst       Date:  2015-04-02       Impact factor: 13.506

7.  Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells.

Authors:  L Klein-Hitpass; A C Cato; D Henderson; G U Ryffel
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

8.  Human carboxyl-terminal variant of alpha-type c-erbA inhibits trans-activation by thyroid hormone receptors without binding thyroid hormone.

Authors:  M A Lazar; R A Hodin; W W Chin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 9.  Genetic alterations in primary breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

Review 10.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.